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Abstract
Mechanistic understanding and defining novel therapeutic targets of diabetic retinopathy and age-related macular
degeneration (AMD) have been hampered by a lack of appropriate adult animal models. Here we describe a simple and
highly reproducible adult fli-EGFP transgenic zebrafish model to study retinal angiogenesis. The retinal vasculature in the
adult zebrafish is highly organized and hypoxia-induced neovascularization occurs in a predictable area of capillary
plexuses. New retinal vessels and vascular sprouts can be accurately measured and quantified. Orally active anti-VEGF
agents including sunitinib and ZM323881 effectively block hypoxia-induced retinal neovascularization. Intriguingly,
blockage of the Notch signaling pathway by the inhibitor DAPT under hypoxia, results in a high density of arterial sprouting
in all optical arteries. The Notch suppression-induced arterial sprouting is dependent on tissue hypoxia. However, in the
presence of DAPT substantial endothelial tip cell formation was detected only in optic capillary plexuses under normoxia.
These findings suggest that hypoxia shifts the vascular targets of Notch inhibitors. Our findings for the first time show a
clinically relevant retinal angiogenesis model in adult zebrafish, which might serve as a platform for studying mechanisms of
retinal angiogenesis, for defining novel therapeutic targets, and for screening of novel antiangiogenic drugs.
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Introduction
Pathological angiogenesis in the retina is the leading cause of
human blindness resulting from diabetic retinopathy, age-related
macular degeneration (AMD), and retinopathy of prematurity
(ROP). Despite of significant advances in medical care, diabetic
retinopathy, AMD and ROP continue to remain the leading causes
of vision impairment and blindness in adults and infants respectively
[1–4]. These common ocular disorders are characterized by
overgrowthofdisorganized,leakyandphysiologicallynon-functional
retinal vessels, which lead to vision impairment and blindness [1,4].
A good adult animal model that recapitulates clinical pathology of
retinal angiogenesis does not exist [5,6]. Thus, there is a great and
urgent need todevelop clinically relevant retinopathymodelsinboth
newborn and adult animals for studying mechanisms of pathological
neovascularization in the retina, screening of novel drugs, and
validating antiangiogenic therapy.
In humans, the posterior part of the eye is nourished by two
vascular networks, the choroidal and retinal vascular systems,
which nourish the outer and inner layers of the retina, respectively
[4,5,7]. During embryonic development, the inner layer of retinal
vasculature is absent and nourishment of the retina is accom-
plished by choroidal and hyaloid vessels [8]. The hyaloid
vasculature is a transient vascular network, which is attached to
the lens and undergoes progressive regression as the retinal
vasculature develops and matures. In ROP, the leading cause of
blindness in infants, high O2 perfusion leads to termination of
hyaloid vessel regression and the formation of premature retinal
vasculature [4,9]. A rodent model has been developed to imitate
human ROP in which newborn mice are exposed to hyperoxia
[10]. Upon return to normoxia, the infant retina is relatively
hypoxic leading to pathological angiogenesis. However, this model
does not accurately reproduce human ROP.
ManylinesofevidencesupporttheideathatalterationofO2levels
is the key driving force of initiating pathological neovascularization.
These include: 1) Pathological retinal angiogenesis occurs in
association with retinal ischemia in several diseases [11,12]; 2)
Development of retinal vasculature in embryos is determined by O2
gradients [4,13]; 3) Hypoxia-inducible VEGF expression levels are
spatiotemporally coupled to retinal neovascularization [4,9,13,14];
and 4) Anti-VEGF agents show remarkable therapeutic efficacy in
both animal and human ophthalmologic disorders characterized by
retinal neovascularization [4,9,13–21]. These findings point to
hypoxia-induced VEGF as the key angiogenic molecule responsible
for retinal neovascularization. Indeed, the newly formed retinal
vessels in AMD, diabetic retinopathy and ROP share unique
features with VEGF-induced vascular networks. For example,
pathological retinal vessels are premature, highly disorganized, and
leaky. In fact, AMD, diabetic retinopathy and ROP all manifest
severe retinal edema, leading to impairment of vision [5].
High VEGF levels in ischemic retinas might reflect a
compensatory mechanism by which VEGF intends to improve
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vasculature consists of disorganized and leaky primitive vascular
networks leading to retinal edema and impairment of vision [22–
27]. Thus, VEGF has become an attractive key target for
development of new drugs against ocular diseases. Not surpris-
ingly, both animal studies and clinical experiences demonstrate
that blockage of VEGF signaling is a valid approach for the
treatment of AMD although the therapeutic efficacy for diabetic
retinopathy and ROP needs further validation in appropriate
animal models. VEGF binds to both VEGFR-1 and VEGFR-2
mainly distributed in endothelial cells and it is VEGFR-2 that
mediates active angiogenic and vascular permeability functions
[28–32]. Thus, VEGFR-2 has become an attractive therapeutic
target for treatments of several common human diseases including
cancer and AMD.
The Notch signaling pathway has recently been highlighted in
contributing to pathological angiogenesis [33–35]. Notch ligand
DLL-4 acts as a negative feedback mechanism downstream of the
VEGF signaling pathway and regulates endothelial cell differen-
tiation, arterial sprouting, vascular remodeling and patterning,
vessel maturation, and vessel stability [36]. Inhibition of the Notch
pathway lead to reduced tumor growth, but increased formation of
non-functional vasculature [37,38]. However, while the role of
Notch in vascular development has been studied in embryos or
infant animals little is known about its function in adult
pathological angiogenesis of non-malignant tissues, and particular
its relation to tissue hypoxia [39,40].
The retinal vasculature of adult zebrafish shares some
similarities with that of humans. For example, mural cell coating,
endothelial cell junctions, and basement membrane composition
are similar in humans and zebrafish [13]. Thus, a retinal
neovascularization disease model in adult zebrafish would be
invaluable for understanding molecular mechanisms of retinal
pathology, defining novel therapeutic targets and for drug
validation. In this paper, we for the first time, describe such a
highly reproducible ocular disease model in adult zebrafish.
Methods
Zebrafish strain and maintenance
Fli-EGFP-Tg zebrafish were purchased from the ZIRC fish
center (Oregon) and maintained in aquaria according to standard
procedures on a 10-h dark/14-h light cycle at 28.5uC [43].
Approximately 5–18-month-old adult zebrafish were used for all
experiments. Before experimental operations, all zebrafish were
anaesthetized with 0.02% tricaine (Sigma). The zebrafish facility
and all experimental procedures were approved by the North
Stockholm Experimental Animal Ethical Committee.
Experimental hypoxia
The hypoxia device was engineered to perfuse N2 gas directly
into the water via an air diffuser and the aquarium was virtually
sealed to prevent leaking air. The N2 gas flow was engaged/
disengaged by a valve, which was controlled by an O2 regulator
(All from Loligo Systems, Denmark). The O2 regulator controlled
the O2 tension via an electrode and the entire hypoxia system was
automated to maintain a constant level of O2 in the aquaria water.
The temperature of the aquaria water remained at 26uC, which
was maintained by using a thermostat. Zebrafish were first placed
in normoxic water and the O2 tension was gradually reduced to
adopt the final 10% air saturation (820 ppb) over the course of 48–
72 h. Zebrafish was exposed in this hypoxic environment for
different time points with a maximal period of 15 days.
VEGF and Notch blockage
Fli-EGFP-Tg zebrafish exposed in the hypoxic condition as
described above were also incubated with 0.5 mM sunitinib or
1 mM ZN323881 for 15 days. The final concentration of the
vehicle (sodium citrate or DMSO respectively) was less than
1:40,000. For Notch inhibition, DAPT (N-[N-(3,5-difluorophena-
cetyl)-L-alanyl]-S-phenylglycine t-butyl ester; Sigma-Aldrich) from
a stock of 10 mM in DMSO was added to the aquaria water to
achieve a final concentration of 10 mM and zebrafish were
incubated for 5 days and under hypoxia or 6 days under
normoxia. During this period of experimentation, no obvious
toxicity was observed with the anti-VEGF compounds or DAPT.
Preparation of retina
Before examination of retinal neovascularization, fli-EGFP-Tg
zebrafish were killed by a lethal dose of MS-222, followed by
decapitation. Fish heads were immersed immediately in 4% PFA,
incubated at 4uC overnight and eyes were enucleated. Retinas
were isolated from the other tissues and flat-mounted onto glass
slides. As for mouse retinas, adult C57/Bl mice were used and eyes
were enucleated after exposure to a lethal dose of CO2. The
isolated mouse retina was immunohistochemically double stained
with a rat anti-mouse CD31 and a mouse anti-human a-SMC
actin antibody as previously described [44].
Confocal analysis
Tissue slides were examined under a confocal microscope (Zeiss
Confocal LSM510). Mouse retinas were scanned and 5 thin
sections (z-thickness: 4–5 mm ) of each sample were assembled into
three-dimensional images. Quantitative analysis from at least 12
different tissue sections was performed using the color range tool of
Adobe Photoshop CS2 version 9.0.2 software program.
Statistic analysis
Data is presented as the mean determinants (6SEM). A
standard student t-test was used for statistical analysis. p,0.05 is
considered significant; p,0.01 is considered highly significant; and
p,0.001 is considered extremely significant.
Results
Retinal vascular networks in adult zebrafish
Development of the retinal vasculature in zebrafish embryos has
been described elsewhere [13]. The retinal vascular structure and
architecture were revealed using adult fli-EGFP transgenic (fli-
EGFP-Tg) zebrafish [41]. An overview of the retinal vasculature
located at inner limiting membrane showed highly organized
vascular patterns with the optic artery (OA) located in the center of
the optic disc (Fig S1A–F). Approximately 4–9 main vessel
branches derived from the optic artery were distributed in each
optic disc and they were further divided 2–5 times (grade I–V)
before anastomosing with circumferential vein capillaries (CVC).
Branch numbers in the grade I optic arteries varied between
individual vessels. In contrast, CVCs directly anastomosed to the
finest grade of arterial capillaries and drained into the circumfer-
ential vein (CV), which encircled the entire optic disc (Fig. S1A–F).
Thus, highly organized and double-ended capillary plexuses
formed a unique vascular pattern before entering into the CV.
Anastomosed arterial-vein capillary plexuses might be susceptible
to growth and sprouting in response to angiogenic stimuli. In
contrast to zebrafish, the mouse retinal vasculature in the inner
membrane of the retina is radially co-distributed with neurons and
glia. Optic arteries and veins form a high density of capillary
Zebrafish Retinal Angiogenesis
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thirds of the optic disc (Fig. S1G–H).
Hypoxia-induced retinal neovascularization in adult
zebrafish
To study retinal neovascularization in a pathological settings,
we have engineered a hypoxia device for zebrafish (Fig. 1J). In this
device, an N2 tank was equipped with a pressure indicator, and
connected to an air-diffuser submerged in the aquaria water. The
aquarium was sealed and the N2 flow was regulated by a solenoid
valve controlled by an O2 regulator. The entire system was
automated and O2 pressure was self-regulated. Tested drugs could
be directed added into water of the sealed aquarium.
Under hypoxia, the optic capillary plexuses of optic arterioles
and veins formed new sprouts that during 12 days in 10% air
saturation grew to become a high density of capillary networks as
compared with those of controls (Fig. 1A, B, D, E, G, H, and K).
Figure 1. Hypoxia-induced retinal angiogenesis in adult fli-EGFP-Tg zebrafish. Adult fli-EGFP-Tg zebrafish were placed in a hypoxic aquaria
and air saturation in the water was controlled at 10% (820 ppb) by an automated device (J). After 12-days exposure to this hypoxic environment,
retinal angiogenesis in the capillary plexuses was detected (B, E, H, and K). Corresponding areas of the retinal vasculture exposed to normoxia were
used as controls (A, D and G). Numbers of new vascular branches and sprouts, intercapillary distances, and total vascularization areas were accurately
quantified (C, F, I, and L). Yellow arrowheads point to vascular sprouts. Yellow arrows point to endothelial tips. Data represents mean determinants of
11–16 randomized samples. ***p,0.001. Bar in panels A and B=100 mm; in panels D and E=50 mm; and in G and H=20 mm.
doi:10.1371/journal.pone.0002748.g001
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with other sprouts derived from neighboring capillaries (Fig. 1H).
In addition, capillary endothelial cell tips were formed at the
leading edge of the sprouts (Fig. 1K). Owing to the highly
organized vascular architecture of retinal vessels, new vessel
branches, sprouts, intercapillary distances, and vascularization
area were accurately quantified and significant differences existed
between normoxia- and hypoxia-treated zebrafish (Fig. 1C, F, I,
and L).
Time course analysis showed that retinal neovascularization
became obvious after exposure to hypoxia for 3 days and increased
angiogenic responses were detected at day 6 and day 12 (Fig. 2A–
H). At day 12, retinal neovascularization reached a plateau of
maximal angiogenic responses. Quantification analysis of the
formation of branches and sprouts, intercapillary distances and
vascularization areas of the capillary plexuses showed significant
differences as compared with those of controls at all time points
after exposure to hypoxia, suggesting that retinal vascularization is
a relatively rapid process in adult zebrafish.
Exposure of adult zebrafish to various concentrations of air-
saturated water showed a dose-dependent angiogenic response to
hypoxia (Fig. 3A–J). Although a significant number of angiogenic
sprouts occurred at 20% air, the formation of new branches was
barely detectable. In contrast, overwhelming retinal angiogenesis
was detected in response to 10% air saturation. It should be
indicated that a considerable number of adult zebrafish would die
if the air saturation was below 10%.
Blockage of retinal neovascularization by oral anti-VEGF
agents
It is known that hypoxia induces VEGF expression via the
hypoxia inducible transcription factor (HIF) system [18,42]. To
study the role of VEGF and VEGFRs in hypoxia-induced retinal
neovascularization in adult zebrafish, known orally active VEGFR
inhibitors were tested. Sunitinib and ZN323881, two potent anti-
VEGFR-2 agents, almost completely blocked hypoxia-induced
retinal neovascularization (Fig. 4A–F). Formation of new vascular
branches was virtually totally inhibited by sunitinib and
ZN323881 (Fig. 4A–H). Similarly, intercapillary distances and
retinal neovascularization areas were also normalized to the levels
of retinas exposed to normoxia (Fig. 4I and J). These findings
indicate that the hypoxia-triggered VEGF signaling pathway is the
primary angiogenic driving force for retinal neovascularization in
adult zebrafish. Thus, our zebrafish retinal angiogenesis model
recapitulates clinical disease settings showing that VEGF plays a
pivotal role in pathological neovascularization in the retina.
Regulation of hypoxia-induced retinal angiogenesis by
the Notch signaling pathway
The Notch signaling pathway has recently been reported to
regulate vascular tip cells formation, vascular sprouting and vascular
remodeling [36,39,40]. To study molecular mechanisms of hypoxia-
induced retinal angiogenesis, the Notch signaling pathway was
inhibited by addition of DAPT, a specific inhibitor for c-secretase,
Figure 2. Time-course of hypoxia-induced retinal neovascularization. Hypoxia-induced retinal neovascularization in adult fli-EGFP-Tg
zebrafish was kinetically monitored (A–H). Angiogenic sprouts were readily formed at day 2 and became overwhelmingly pronounced at day 3 (B)
after exposure to hypoxia. The hypoxia-induced retinal angiogenic vessels continued to grow between days 3–12 (B–D). A maximal angiogenic
response was detected at day 12. Quantification of new vessel branches (E), sprouts (F) intercapillary distances (G), and total vascularization areas (H)
showed significant differences at all time points. Yellow arrowheads point to vascular sprouts. Data represents mean determinants of 11–16
randomized samples. ***p,0.001. Bar=50 mm.
doi:10.1371/journal.pone.0002748.g002
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DAPT, virtually all optic arteries form an exceptionally high density
of sprouts, which constituted a disorganized vascular network in
proximity to the central optical artery (Fig. 5A, E, and I). High
magnification analysis of these arterial sprouts revealed endothelial
tip cells forming at the migrating leading edges (Fig. 5I, arrows). The
arterialsprout/branchformationwascompletelydependentontissue
hypoxia. Under normoxia, DAPT did not induce the formation of
any arterial sprouts/branches, suggesting that hypoxia was the
driving force when the Notch signaling was inhibited (Fig. 5B and F).
Interestingly, inhibition of the Notch signaling pathways by
DAPT did not increase the hypoxia-induced sprouting and branch
formation in the optic capillary plexus area (Fig. 5C, G, and K),
suggesting that the negative feedback effect of Notch under tissue
hypoxia was limited to the arterial vasculature close to the central
optical artery. Surprisingly, inhibition of the Notch under normoxia
led to formation of endothelial cell tips in the entire area of capillary
plexuses (Fig. 5D, H, and L). These capillary endothelial cell tips
were randomly formed from all capillary endothelial cells and were
non-directionally distributed in all capillary plexuses (Fig. 5L).
Intriguingly, these capillary endothelial tips were rarely detectable
under hypoxia in the presence of DAPT, suggesting the hypoxia
might suppress endothelial tip cell formation in capillary networks.
Discussion
Retinopathy, AMD, and other retinal disorders caused by the
diabetes epidemic and the change in life style demands
development of effective and less expensive targeted therapeutic
drugs. For this purpose, development of better animal disease
models that recapitulate pathological neovascularization in the
retina and clinical retinopathy is urgently needed. Such an in vivo
disease model in adult animals would serve as a platform for
understanding the underlying mechanism of retinal angiogenesis,
for discovery of novel antiangiogenic drugs, and for evaluation of
therapeutic efficacy of existing antiangiogenic agents. Unfortu-
nately, a simple and clinically relevant animal model does not exist
[5,6]. In this paper, we report that an adult zebrafish retinal
angiogenesis model imitates pathological retinal neovasculariza-
tion that is relevant to clinical settings . To the best of our
knowledge, this is the first report describing the development of a
non-invasive adult zebrafish model to study retinal angiogenesis.
Figure 3. Dose-dependent hypoxia-induced retinal neovascularization. Adult fli-EGFP-Tg zebrafish were exposed to 20% or 10% air-
saturated water for 6 days. Retinal neovascularization was analyzed using whole-mount confocal analysis and quantified as branching points,
numbers of sprouts, intercapillary distances, and total vascularization areas (A–J). Yellow arrowheads point to vascular sprouts. Data represents mean
determinants of 11–25 randomized samples. *p,0.05. ***p,0.001. Bar=50 mm
doi:10.1371/journal.pone.0002748.g003
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retinal disorders. Zebrafish and human retinal vasculatures share
some common features. Anatomically, the central retinal artery in
zebrafish and humans contributes to angiogenesis and the
formation capillary plexuses [13]. Developmentally, an initial
hyaloid vasculature is associated with the lens and becomes
separated at later stage of development [13] (our unpublished
data). Similar to humans, the retinal vasculature in the adult
zebrafish is also enriched in pericytes and shares some common
compositions of ECM and basal lamina [13]. Our zebrafish model
has several significant advantages as compared with other existing
retinal angiogenesis models including the most commonly used
ROP and laser-induced choroidal neovascularization. These
include: 1) Non-invasive induction of retinal angiogenesis in the
adult animal; 2) Highly reproducible retinal neovascularization in
capillary plexuses; 3) Simple, easy and fast experimental
procedures; 4) Fli-EGFP-Tg zebrafish avoids immunohistochem-
ical procedures; 5) Easy approval by the ethical committee; 6)
Low-cost zebrafish facility; 7) Screening of antiangiogenic drugs in
a real disease model; 8) Study of vascular patterning, remodeling,
and molecular mechanisms of pathological angiogenesis; and 9)
Therapeutic evaluation of orally active antiangiogenic agents.
In this adult zebrafish model, we have discovered some
unexpected roles of the Notch signaling pathway in relation to
tissue hypoxia for regulation of retinal angiogenesis. Under
normoxia, inhibition of Notch only leads to capillary endothelial
tip sprouting without stimulating the formation of new capillaries.
These findings suggest that Notch signaling restricts capillary tip
sprouting under physiological conditions. However, without
hypoxia as a driving force the formation of capillary endothelial
tips would not lead to establishment of functional capillary
networks. Inhibition of Notch in the presence of hypoxia
completely alters the angiogenic targets from capillary networks
to the arterial vasculature. Although the underlying mechanisms
remain uncharacterized, it is possible that inhibition of the Notch
pathway might lead to repelling of pericytes or smooth muscle cells
from arterial vessels, which then become susceptible to VEGF
stimulation. This would not explain why capillary tip cells
disappeared under hypoxia and Notch inhibition. Probably,
hypoxia might inhibit capillary tip cell formation in the absence
of notch. These interesting findings warrant further mechanistic
investigation. Nevertheless, our findings suggest that hypoxia
might alter the target of Notch inhibitors. For development of
therapeutic agents targeting the Notch signaling pathway for the
Figure 4. Inhibition of retinal neovascularization by orally active anti-VEGF drugs. Adult fli-EGFP-Tg zebrafish were exposed to 10 %
hypoxia in the absence (A) or presence of sunitinib (B and E) or ZN323881 (C and F) anti-VEGF small molecules for 14 days. Retinal neovascularization
was analyzed using whole-mount confocal analysis and quantified as branching points (G), numbers of sprouts (H), intercapillary distances (I), and
total vascularization area (J). Yellow arrowheads point to vascular sprouts. Data represents mean determinants of 11–29 randomized samples.
*p,0.05. ***p,0.001. Bar=50 mm.
doi:10.1371/journal.pone.0002748.g004
Zebrafish Retinal Angiogenesis
PLoS ONE | www.plosone.org 6 July 2008 | Volume 3 | Issue 7 | e2748Figure 5. Inhibition of Notch under hypoxia and normoxia. Adult fli-EGFP-Tg zebrafish were exposed to 10 mM DAPT under hypoxia for 5
days (A, E, I, C, G, and K) or under normoxia for 6 days (B, D, F, H, and L). Control optic arteries without exposure to hypoxia or DAPT are shown in (J).
E–H are amplified images of the inserts of A–D. Retinal neovascularization was analyzed using whole-mount confocal analysis and quantified as
numbers of arterial sprouts (M), capillary tips (N) or branch formations (O).Yellow arrowheads point to vascular sprouts. Yellow arrows point to
endothelial tips. The dashed red lines encircle the central optic artery. Data represent mean determinants of 11–13 randomized samples. *p,0.05.
***p,0.001. Bars in A–D=100 mm; Bars in A–D=50 mm; and Bars in A–D=20 mm.
doi:10.1371/journal.pone.0002748.g005
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understand the relation between Notch and tissue hypoxia since
pathological retinas in most ocular disorders including diabetic
retinopathy, AMD and ROP are exposed to severe tissue hypoxia.
Both AMD and diabetic retinopathy are adult-onset disorders
characterized by the formation of primitive, leaky and disorganized
vascular networks, which grow into the vitreous [4,17]. These
features of the retinal vasculature might reflect the unique aspects of
VEGF function that include induction of disorganized, highly leaky,
tortuous and primitive vascular networks. A large body of studies
demonstrates that VEGF is the primary molecule responsible for
pathological angiogenesis in the retina of AMD and diabetic
retinopathy [16,17,19–21]. Indeed, clinical experiences with anti-
VEGF agents for the treatment of AMD have shown remarkably
beneficial effects [16]. Expression levels of VEGF are primarily
regulated by tissue hypoxia via the HIF system [18,42]. With no
exception in the pathological retina of AMD and retinopathy,
hypoxia is the key element of retinal neovascularization. However in
mammalianmodels,itis difficultto develop ahypoxia-induced retinal
angiogenesis model in adult animals. Although the infant ROP model
in mice is also based on mechanisms of the hypoxia-induced
angiogenesis, exposure to normal air is considered as a relative
hypoxia. Thus, this model is not considered as a true disease model.
Our findings show that similar to humans the retina of zebrafish
responds to hypoxia, which initiates pathological angiogenesis. We
further demonstrate that orally active angiogenesis inhibitors could
significantly inhibit retinal neovascularization, suggesting that
VEGF is responsible for the hypoxia-induced angiogenesis.
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